(R)-5-[2-(2,5-Difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidine is a chiral, heterocyclic compound featuring a pyrazolopyrimidine core linked to a 2,5-difluorophenyl-substituted pyrrolidine ring. This specific stereochemistry (R-configuration) is crucial for its biological activity. This compound is a key intermediate in the synthesis of novel, potent, and selective orexin receptor antagonists. Orexin receptors (OX1R and OX2R) are G-protein-coupled receptors involved in regulating sleep-wake cycles, arousal, and appetite. Antagonists targeting these receptors are being actively developed as therapeutics for insomnia and other sleep disorders. The pyrazolopyrimidine-pyrrolidine scaffold is a privileged structure in medicinal chemistry for central nervous system (CNS) drug discovery. As a high-value pharmaceutical intermediate, its synthesis and supply are critical for the research and development of next-generation sleep aids. The presence of fluorine atoms often enhances metabolic stability and membrane permeability, which are desirable properties for CNS-active drugs.